Spotlights

RYTHM (RYM): From Vertical Farming to Hemp THC Brands

mm
Add MyCannabis.com to your preferred sources on Google

When you hear the name “RYTHM,” you might expect something rhythmic or musical. But in the world of cannabis tech and branding, this name marks a notable transformation. Formerly known as Agrify Corporation (AGFY ) , a company that built its reputation on vertical farming and cultivation-technology solutions for cannabis operators, RYTHM, Inc. (RYM ) is charting a new course in the hemp-derived THC and brand licensing space.

Overview

Agrify began life as a provider of advanced hardware and software solutions for indoor cannabis cultivation. Its flagship offering included Vertical Farming Units (“VFUs”), along with Agrify Insights™, its cultivation-software suite. Backed by white paper claims of yield improvement and enhanced control, Agrify served craft growers, multi-state operators, and large indoor facilities.

Over time, the company built out its cultivation and extraction solutions division, offering both hardware to deploy indoor grows and software services to monitor, manage, and analyze cultivator performance. Beginning in January 2025, the company began a sharp pivot: it sold the cultivation business and later re-branded, announced brand acquisitions and licensing deals, and changed its name to RYTHM Inc. The rebrand officially took effect with the ticker symbol change to RYM on September 2, 2025.

Under the new name, RYTHM emphasizes consumer-facing hemp-derived THC brands and licensing models rather than purely cultivation-technology hardware. The company expects to generate revenue from brand licensing, hemp-THC product sales, and leverage its prior technological credibility in a new business model.

Cannabis Market Position

RYTHM occupies a somewhat hybrid position in the cannabis ecosystem: it has roots in cultivation-tech, but its future direction emphasizes branded consumer products derived from hemp-THC. This shift carries both opportunities and complexities.

On the one hand, RYTHM’s prior technology business gave it industry credibility. For example, in 2022 Agrify received the “Best Cultivation Technology” award from the Green Market Report for its VFU + software system.  The VFU platform was designed to maximize floor-space utilization, bring vertical stacking, and provide micro-climate control, enabling high-density indoor grows with data feedback loops.

On the other hand, the shift away from hardware and technology to brand licensing and hemp-derived product sales reflects recognition of the broader challenges facing indoor-cultivation hardware: high capital costs, long payback periods, and a cannabis industry under regulatory stress. In January 2025, Agrify closed the sale of its cultivation business to simplify its business and focus on hemp-THC products and brand assets.

RYTHM’s market position today is less about selling grow-equipment and more about monetizing the premium consumer-brand world of hemp-derived THC, leveraging previous industry relationships, and licensing manufacturing and distribution to third parties. In August 2025, the company announced the acquisition of a brand portfolio (including RYTHM, Dogwalkers, and Beboe) from Green Thumb Industries for US$50 million via convertible note, coupled with a licensing agreement for Green Thumb to manufacture and distribute those brands.

The upside is that if hemp-derived THC brands gain regulatory acceptance, have broad consumer appeal, and licensing scales, RYTHM could leverage its brand advantages and legacy tech credibility. But the company also faces competition in the brand and consumer packaged goods space, regulatory uncertainties around hemp-THC, and the challenge of monetizing a business model transition.

Financial Performance and Strategy

Like many companies in the ancillary cannabis ecosystem, RYTHM’s (formerly Agrify’s) financials reflect transitions, restructuring, and strategic pivots rather than stable high-margin profits. Typical financial metrics for investors to watch include revenue growth (or decline), recurring vs one-time hardware sales vs software/SaaS payments, margin profile, and cash-flow/asset-base adjustments.

In its prior incarnation, Agrify’s business hinged heavily on the sale of VFUs and servicing and software revenue. For example, contracts in 2024 included multiple-year agreements with recurring SaaS/production-success fees tied to VFU installation.  Then, the company announced the sale of its cultivation business under the rationale of simplifying and focusing on higher-growth categories.

With the brand acquisition and rebranding to RYTHM, the strategy now emphasizes licensing revenue from acquired brands, hemp-derived THC consumer products, and a smaller capital footprint (less heavy hardware/extraction investment).

For investors, this means the business is shifting from capital-intensive hardware and services toward potentially higher-margin and scalable brand licensing. But there are potential trade-offs: hardware/installation revenue may shrink, recurring software revenue may take longer to scale, and the consumer-goods branding business brings different risks (marketing, margin, brand adoption) than cultivation technology.

(RYM )


Sarah Schwefel is a journalist, research analyst, speaker, and patient advocate. After relocating for access to cannabis for her own health, she became engulphed in the cannabis and hemp industry determined to better help herself and other patients. In 2020, she became certified in endocannabinoid medicine studies from the American Journal of Endocannabinoid Medicine. Sarah uses her expertise to educate and advocate through her writing on various topics including legislation and the benefits plant medicine offers.